Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Treatment”

6,957 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 6,957 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04305496
What this trial is testing

Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer

Who this might be right for
Locally Advanced (Inoperable) or Metastatic Breast Cancer
AstraZeneca 818
Not applicableStudy completedNCT03729661
What this trial is testing

Exploratory Study on Therapy for Breath Hold in Radiotherapy

Who this might be right for
Lung CancerBreast Cancer
Maastricht Radiation Oncology 20
Not applicableStudy completedNCT02956473
What this trial is testing

Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 57
Not applicableStudy completedNCT00773669
What this trial is testing

Male Breast Cancer Summa Health System/Akron City Hospital Experience 1995-2007

Who this might be right for
Breast Cancer
Summa Health System 24
Testing effectiveness (Phase 2)Looking for participantsNCT05190094
What this trial is testing

Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies.

Who this might be right for
Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer
International Cancer Research Group, United Arab Emirates 80
Not applicableStudy completedNCT02403973
What this trial is testing

Trial Comparing Perioperative Care for Breast Cancer Patients at a Patient Hotel vs a General Surgical Ward

Who this might be right for
Breast Cancer
Danderyd Hospital 151
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07658183
What this trial is testing

A Clinical Trial Comparing the Efficacy and Safety of Different Doses of BL0175 Injection in Treating Postmenopausal Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer (Locally Advanced or Metastatic)
Shanghai Best-Link Bioscience, LLC 120
Not applicableLooking for participantsNCT03390894
What this trial is testing

Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies

Who this might be right for
Invasive Breast Cancer Early Stages
Spanish Breast Cancer Research Group 8,000
Not applicableStudy completedNCT01873794
What this trial is testing

Treating Cancer-Related Fatigue Through Systematic Light Exposure

Who this might be right for
Hematopoietic Stem Cell TransplantationBreast CancerFatigue+4 more
Icahn School of Medicine at Mount Sinai 54
Large-scale testing (Phase 3)Ended earlyNCT00130494
What this trial is testing

Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions

Who this might be right for
Breast CancerNeoplasm Metastasis
Spanish Breast Cancer Research Group 97
Not applicableNot Yet RecruitingNCT06193122
What this trial is testing

Three-Dimensional Ultrasound and Spectroscopy as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment

Who this might be right for
Breast Cancer
Sunnybrook Health Sciences Centre 200
Not applicableEnded earlyNCT04370522
What this trial is testing

Characterization of Innate Immune System in Patients With Luminal Advanced Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Spanish Breast Cancer Research Group 32
Not applicableUnknownNCT01432002
What this trial is testing

FDG-PET/CT for Simulation and Radiation Treatment Planning of Early Breast Cancer

Who this might be right for
Breast Neoplasm
University Hospital, Geneva 60
Very early researchStudy completedNCT03387553
What this trial is testing

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

Who this might be right for
Breast CancerBreast Cancer FemaleBreast Cancer, Male+5 more
H. Lee Moffitt Cancer Center and Research Institute 31
Testing effectiveness (Phase 2)Study completedNCT00003796
What this trial is testing

Irofulven in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT07192588
What this trial is testing

GR1014 Cutaneous Gel for the Prevention of Skin Reactions Caused by Radiation Therapy for Breast Cancer

Who this might be right for
Radiodermatitis; Acute
Graegis Pharmaceuticals Ltd 273
Not applicableEnded earlyNCT02149173
What this trial is testing

F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy

Who this might be right for
Estrogen Receptor PositiveRecurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7
University of Washington 29
Not applicableStudy completedNCT00156273
What this trial is testing

Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
University of Michigan Rogel Cancer Center 69
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07005583
What this trial is testing

Clinical Study of QL1706 in Combination With Olaparib for the Treatment of Patients With Previously Treated Homologous Recombination Repair-Deficient Recurrent or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer (TNBC)
Tianjin Medical University Cancer Institute and Hospital 46
Not applicableUnknownNCT05051956
What this trial is testing

Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?

Who this might be right for
Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors
Namik Kemal University 140
Next Page